Unless the party in the territory in which the resources are located is made otherwise, access to genetic resources is subject to prior approval by the country of origin (Article 6.1). National legislation should determine when IDPs are needed for all genetic resources, for certain categories of resources, or for specific access purposes. It should also provide exceptions to the requirement, for example. B for non-commercial research (for which simplified actions are planned). National legislation should also provide for an access determination procedure. This should include information that must be provided by applicants on how applications should be reviewed, the criteria for assessing the application and the appeal procedure. Access may be subject to agreement on mutually agreed terms (MAT) for the distribution of benefits. (n) the institutional and professional relations that may result from an agreement on access and distribution of the benefits and cooperation activities that follow; Note that not all countries have a priority! Also note that focal points are only responsible for providing information on ABS authorizations and agreements; Countries may have other licensing requirements for which this point of contact is unable to provide advice. The Nagoya Protocol on Access to Genetic Resources and the Equitable and Fair Sharing of Benefits from Their Use came into effect on October 12, 2014. It is an international convention adopted under the Convention on Biological Diversity (CDB). The Nagoya Protocol proposes a directive for the effective implementation of the third CBD objective. An Access and Benefits Sharing Agreement (ABSA) is an agreement that defines the fair and equitable sharing of benefits from the use of genetic resources.
ABS are generally created in terms of bioprospecting, where indigenous knowledge is used to focus screening efforts for genetic and biochemical resources of commercial value. ABSas recognize that bioprosperation is often based on aboriginal or traditional knowledge and that individuals or communities with such knowledge are entitled to a share of the benefits of their commercial exploitation. Open access to biodiversity research data and corresponding samples at final storage sites is essential for non-commercial basic biological science and is essential to support CBD objectives. SICN member institutions are committed to acquiring, using and managing genetic resources in accordance with international conventions and national laws and regulations. As a result, GGBN has developed material transfer agreements, a code of conduct and best practice guides for member use. It is recommended that CIS members provide information on the origin of samples when supplying or transferring equipment (which may be required by national law, as in all EU Member States). Monitoring and downstream monitoring of the genetic resources used is a recognized challenge. In response to this challenge, the GGBN has developed an authorisation vocabulary under the GGBN data standard, which helps standardize the tracking of authorization information for genetic resource registrations in GGBN member institutions and beyond. By 2020, it is imperative that all CIS member institutions that provide data to the SICN data portal associate associated information on authorizations and compliance agreements with models collected on or after October 12, 2014. Countries have the right to regulate how biodiversity is achieved and used, as defined in the 1992 UN Convention on Biological Diversity (CDB).